Skip to content

MAGNUM MN1613Recalls & reported problems

Bard Peripheral Vascular, Inc. · MAGNUM® Disposable Core Tissue Biopsy Needle, 16g x 13cm · Class 2

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00801741084294), received between Sep 28, 2023 and Sep 28, 2023 — classified as 1 malfunction.

The most frequently reported specific device problem is “Device Contamination with Chemical or Other Material” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Most reported problems

Device problems

  • Device Contamination with Chemical or Other Material1
  • Tear, Rip or Hole in Device Packaging1

Patient problems

  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionSep 28, 2023Tear, Rip or Hole in Device Packaging; Device Contamination with Chemical or Other Material; Tear, Rip or Hole in Device Packaging; Device Contamination with Chemical or Other Material

    IT WAS REPORTED THAT UPON INSPECTION OF FORTY UNITS OF UNUSED BIOPSY NEEDLES, THE CLOSED BOX AND INDIVIDUAL EXTERNAL PACKAGING WERE ALLEGEDLY DUSTY. THERE WAS NO REPORTED PATIENT CONTACT.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 17831737 ↗

Other Biopsy needle devices

All Biopsy needle devices →

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.